Physiomics (GB:PYC) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Physiomics plc has appointed Dr. Mark Davies as Head of Quantitative Pharmacology and Data Science, aiming to enhance their Modelling, Simulation and Data Science services. With over 20 years of experience in drug development and data informatics, Dr. Davies is expected to drive growth and operational excellence, expanding the company’s market reach and service offerings. This strategic move is set to strengthen Physiomics’ position in the pharmaceutical and healthtech sectors.
For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.
